Rhumbline Advisers KINIKSA PHARMACEUTICALS INT Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
Number of Shares
58,955
Previous 59,864
1.52%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%